PBM:NASDAQPsyence Biomedical Ltd. analysis
Data as of Oct 19, 2026 - not real-time
- Latest price
- $4.27
- Risk: high
- 9/10High risk
Summary
The moving-average structure behind Psyence Biomedical Ltd. is neutral at $4.27, with no clear ordering between short and long averages. Over a rolling month the price has lost 5.9%. Relative strength is 37.3 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at $4.09 up to resistance at $7.18.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 79.1%, a beta of 2.83 and a maximum drawdown of 98.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 89 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 79.1%, a beta of 2.83 and a maximum drawdown of 98.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 89 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top market events
- Psyence Biomedical Ltd. NASDAQ:PBM has agreed to invest up to $5 million in Psyence Labs Ltd.
- Texas-based company is designed to coordinate U.
- Binding term sheet with PsyLabs provides Psyence BioMed’s Texas subsidiary with exclusive U.
Market outlook
Short term
< 1 yearNeutral
Model confidence2/102 out of 10
Key factors
- Trading below the 200-day average of 5.40
- MACD momentum is negative
- 30-day price change of -5.9%
Medium term
1–3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Trading below the 200-day average of 5.40
- 30-day volatility of 79.1%
- MACD momentum is negative
Long term
> 3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Negative return on equity of -58.6%
- Negative free cash flow
- 30-day volatility of 79.1%
Key metrics
Financial health
ROE-58.62%
ROA-31.33%
P/B Ratio0.6
Op. Cash Flow$-8143007
Free Cash Flow$-4955898
Industry P/E31.5
Technical analysis
TrendNeutral
RSI37.3
Support$4.09
Resistance$7.18
MA 20$5.12
MA 50$4.81
MA 200$5.40
MACDBearish
VolumeDecreasing
Fear & Greed Index88.61
Valuation
GradeFair
TypeBlend
Risk assessment
Beta2.83
Volatility79.12%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.